What patients want from the treatment of Dupuytren's disease - Is the Unité Rhumatologique des Affections de la Main (URAM) scale relevant?

Journal of Hand Surgery: European Volume

Volumn 40, Issue 2, 2015, Pages 150-154

  Rodrigues, J N ^a   Zhang, W ^a   Scammell, B E ^a   Davis, T R C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Dupuytren's disease; goals; outcome; patient reported outcome measure; URAM

Indexed keywords

DISABILITY; DUPUYTREN CONTRACTURE; HUMAN; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PROSPECTIVE STUDY; QUESTIONNAIRE;

DISABILITY EVALUATION; DUPUYTREN CONTRACTURE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 84921650407     PISSN: 17531934     EISSN: 20436289     Source Type: Journal    
DOI: 10.1177/1753193414524689     Document Type: Article

References (13)

1. Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice. BMC Musculoskelet Disord. 2013 ; 14: 131
2. Beaudreuil J, Allard A, Zerkak D, et al. Unite Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability. Arthritis Care Res. 2011 ; 63: 1448-55
3. DarziA. High quality care for all: NHS Next Stage Review final report. London, The Stationery Office, 2008. http://www.official-documents.gov.uk/document/cm74/7432/7432.pdf (accessed 6 February 2014).
4. Department of Health. Equity and excellence: Liberating the NHS. London, The Stationery Office, 2010. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-117353 (Accessed 6 February 2014).
5. Engstrand C, Boren L, Liedberg GM. Evaluation of activity limitation and digital extension in Dupuytren's contracture three months after fasciectomy and hand therapy interventions. J Hand Ther. 2009 ; 22: 21-6
6. Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (Disabilities of the Arm, Shoulder and Hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996 ; 29: 602-8
7. Law M, Baptiste S, McColl M, Opzoomer A, Polatajko H, Pollock N. The Canadian occupational performance measure: an outcome measure for occupational therapy. Can J Occup Ther. 1990 ; 57: 82-7
8. Macey AC, Burke FD, Abbott K, et al. Outcomes of hand surgery. British Society for Surgery of the Hand. J Hand Surg Br. 1995 ; 20: 841-55
9. Mokkink LB, Terwee CB, Knol DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010 ; 10: 22
10. Paterson C. Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. BMJ. 1996 ; 312: 1016-20
11. Szabo RM. Outcomes assessment in hand surgery: when are they meaningful?. J Hand Surg Am. 2001 ; 26: 993-1002
12. van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006 ; 31: 717-25
13. van Rijssen AL, ter Linden H, Werker PMN. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012 ; 129: 469-77